BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12393309)

  • 1. P300 subcomponents in obsessive-compulsive disorder.
    Mavrogiorgou P; Juckel G; Frodl T; Gallinat J; Hauke W; Zaudig M; Dammann G; Möller HJ; Hegerl U
    J Psychiatr Res; 2002; 36(6):399-406. PubMed ID: 12393309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological evidence for cortical abnormalities in obsessive-compulsive disorder - a replication study using auditory event-related P300 subcomponents.
    Gohle D; Juckel G; Mavrogiorgou P; Pogarell O; Mulert C; Rujescu D; Giegling I; Zaudig M; Hegerl U
    J Psychiatr Res; 2008 Mar; 42(4):297-303. PubMed ID: 17328913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological correlates of P300 abnormalities in patients with schizophrenia and obsessive-compulsive disorder.
    Kim MS; Kang SS; Youn T; Kang DH; Kim JJ; Kwon JS
    Psychiatry Res; 2003 Jun; 123(2):109-23. PubMed ID: 12850250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P300 in obsessive-compulsive disorder: source localization and the effects of treatment.
    Andreou C; Leicht G; Popescu V; Pogarell O; Mavrogiorgou P; Rujescu D; Giegling I; Zaudig M; Juckel G; Hegerl U; Mulert C
    J Psychiatr Res; 2013 Dec; 47(12):1975-83. PubMed ID: 24075207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do obsessive-compulsive patients and abstinent heroin addicts share a common psychophysiological mechanism?
    Papageorgiou C; Rabavilas A; Liappas I; Stefanis C
    Neuropsychobiology; 2003; 47(1):1-11. PubMed ID: 12606838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Event-related potentials and neuropsychological tests in obsessive-compulsive disorder.
    Kivircik BB; Yener GG; Alptekin K; Aydin H
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):601-6. PubMed ID: 12787845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological correlates of behavioral response inhibition in patients with obsessive-compulsive disorder.
    Kim MS; Kim YY; Yoo SY; Kwon JS
    Depress Anxiety; 2007; 24(1):22-31. PubMed ID: 16933318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced response-inhibition in obsessive-compulsive disorder measured with topographic evoked potential mapping.
    Herrmann MJ; Jacob C; Unterecker S; Fallgatter AJ
    Psychiatry Res; 2003 Oct; 120(3):265-71. PubMed ID: 14561438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive event-related potentials differentiate schizophrenia with obsessive-compulsive disorder (schizo-OCD) from OCD and schizophrenia without OC symptoms.
    Pallanti S; Castellini G; Chamberlain SR; Quercioli L; Zaccara G; Fineberg NA
    Psychiatry Res; 2009 Nov; 170(1):52-60. PubMed ID: 19800695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontal-striatal dysfunction during planning in obsessive-compulsive disorder.
    van den Heuvel OA; Veltman DJ; Groenewegen HJ; Cath DC; van Balkom AJ; van Hartskamp J; Barkhof F; van Dyck R
    Arch Gen Psychiatry; 2005 Mar; 62(3):301-9. PubMed ID: 15753243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal P600 in obsessive-compulsive disorder. A comparison with healthy controls.
    Papageorgiou CC; Rabavilas AD
    Psychiatry Res; 2003 Jul; 119(1-2):133-43. PubMed ID: 12860367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary evidence for correlation between PASAT performance and P3a and P3b amplitudes in progressive multiple sclerosis.
    Kiiski H; Whelan R; Lonergan R; Nolan H; Kinsella K; Hutchinson M; Tubridy N; Reilly RB
    Eur J Neurol; 2011 May; 18(5):792-5. PubMed ID: 20666835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auditory P300 event related potential and serotonin reuptake inhibitor treatment in obsessive-compulsive disorder patients.
    Sanz M; Molina V; Martin-Loeches M; Calcedo A; Rubia FJ
    Psychiatry Res; 2001 Feb; 101(1):75-81. PubMed ID: 11223122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An electrophysiological study in obsessional compulsive disorders.
    Serra FP; Palma V; Nolfe G; Buscaino GA
    Acta Neurol (Napoli); 1994 Dec; 16(5-6):240-8. PubMed ID: 7709794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auditory event-related potentials and statistical probability mapping in obsessive-compulsive disorder.
    de Groot CM; Torello MW; Boutros NN; Allen R
    Clin Electroencephalogr; 1997 Jul; 28(3):148-54. PubMed ID: 9241468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological study of frontal lobe function in psychotropic-naive children with obsessive-compulsive disorder.
    Beers SR; Rosenberg DR; Dick EL; Williams T; O'Hearn KM; Birmaher B; Ryan CM
    Am J Psychiatry; 1999 May; 156(5):777-9. PubMed ID: 10327915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder.
    Kwon JS; Kim JJ; Lee DW; Lee JS; Lee DS; Kim MS; Lyoo IK; Cho MJ; Lee MC
    Psychiatry Res; 2003 Jan; 122(1):37-47. PubMed ID: 12589881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive function, P3a/P3b brain potentials, and cortical thickness in aging.
    Fjell AM; Walhovd KB; Fischl B; Reinvang I
    Hum Brain Mapp; 2007 Nov; 28(11):1098-116. PubMed ID: 17370342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Event-related potentials in patients with obsessive-compulsive disorder.
    Miyata A; Matsunaga H; Kiriike N; Iwasaki Y; Takei Y; Yamagami S
    Psychiatry Clin Neurosci; 1998 Oct; 52(5):513-8. PubMed ID: 10215013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepant target detection and action monitoring in obsessive-compulsive disorder.
    Johannes S; Wieringa BM; Nager W; Rada D; Dengler R; Emrich HM; Münte TF; Dietrich DE
    Psychiatry Res; 2001 Nov; 108(2):101-10. PubMed ID: 11738544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.